Component information
Different name of ingredient
- Ocrelizumabum
- Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal 2H7 γ1-chain), disulfide with human-mouse monoclonal 2H7 κ-chain, dimer
- PRO70769 (Roche, GB)
- Ocrelizumab
Alternative medicine with selected ingredient
| Name | PZN | Form | Packing | Manufacturer | Price | |
|---|---|---|---|---|---|---|
| Details | OCREVUS 920 mg Injektionslösung 23ml Dsfl. | P18404287 | ILO | 1 St | ROCHE | € 12621.08 |
| Details | OCREVUS 300 mg Konz.z.Herst.e.Inf.-Lsg.10ml Dsfl. | P19457825 | IFK | 2 St | ABACU | € 12621.07 |
| Details | OCREVUS 300 mg Konz.z.Herst.e.Inf.-Lsg.10ml Dsfl. | P15744002 | IFK | 2 St | ROCHE | € 12621.08 |
| Details | OCREVUS 300 mg Konz.z.Herst.e.Inf.-Lsg.10ml Dsfl. | P19753280 | IFK | 2 St | ORI | € 12621.06 |
| Details | OCREVUS 300 mg Konz.z.Herst.e.Inf.-Lsg.10ml Dsfl. | P19630028 | IFK | 1 St | KOHL | € 6339.34 |
| Details | OCREVUS 300 mg Konz.z.Herst.e.Inf.-Lsg.10ml Dsfl. | P19367720 | IFK | 1 St | PARAN | € 6339.34 |